Northwire Canada EditionThursday, October 15, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4% GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4%
Financings Routine +

Liberty Defense Announces Closing of its U.S. Initial Public Offering

Liberty Defense Closes $20M Nasdaq IPO Amidst Contract Momentum and Stock Consolidation

By The Northwire Desk — AI Analysis Apr 24, 2026 · 08:30 SCAN · 6.25 Liberty Defense Holdings, Ltd.
Executive Summary
  • Liberty Defense Holdings Ltd. announced the closing of its U.S. Initial Public Offering (IPO) on April 24, 2026.
  • The offering raised approximately $20 million USD in gross proceeds before expenses.
  • Issuance included over 3.67 million common shares at $4.50 per share and over 770,807 pre-funded warrants (exercise price $0.0001).
  • Shares transitioned from OTCQB Venture Market to Nasdaq Capital Market under symbol "DETX" on April 22, 2026.
  • The company remains listed on the TSX Venture Exchange.
  • Underwriters granted a 30-day over-allotment option for up to an additional 666,666 shares.
  • CEO William Frain participated in the IPO with a purchase of 5,555 common shares ($25,000 gross proceeds).
Material Impact
  • Financing Completion: The closing confirms the $20 million capital raise announced on April 21, 2026. This is expected news as the pricing was publicized three days prior.
  • Market Reaction: Trading price dropped from $7.75 (April 21 pricing) to $6.25 (April 23 listing), indicating the market did not view the IPO terms as a significant upside surprise relative to recent trading levels.
  • Capital Strength: The $20 million USD raise is substantial compared to previous private placements ($2.6M CAD total in late 2025/early 2026), providing runway for production scaling and backlog fulfillment.
  • Listing Upgrade: Transition to Nasdaq improves liquidity and visibility but does not alter the fundamental business risk profile immediately.
  • Dilution Concerns: Significant equity issuance history (LIFE financings + IPO) continues to dilute existing shareholders, which correlates with the stock's 67% decline over the past year despite contract wins.
SCAN · Price
Company Overview
  • Flagship Project: HEXWAVE(TM) AI-driven walkthrough screening system using millimeter-wave imaging and 3D imaging to detect metallic and non-metallic threats (liquids, powders, explosives).
  • Secondary Technology: HD-AIT (High-Definition Advanced Imaging Technology), currently undergoing TSA certification upgrades.
  • Key Contracts:
    • U.S. Transportation Security Administration (TSA) contract option exercised for design improvements (Dec 2025).
    • Major U.S. Airport Contract (>30M passengers annually) for aviation worker screening (Feb 2026).
    • JFK International Airport Terminal One deployment for aviation workers (Nov 2025 announcement, 2026 implementation).
    • Infectious Disease Laboratory contract (Feb 2026).
  • Business Model: Custom security solutions for high-security environments (airports, government facilities, research labs).
Read the original news release →

More from Liberty Defense Holdings, Ltd.

Jun 25, 2026 · 08:30

Next-gen millimeter-wave screening for aviation and critical infrastructure, post-IPO scaling phase.

Other May 27, 2026 · 08:30

Liberty Defense Validates HEXWAVE at LaGuardia While Settling Minor Debt; Stock Consolidates Post-IPO

Financings Apr 21, 2026 · 17:18

Tagline: Liberty Defense Secures Nasdaq Listing Amid Valuation Reset and Capital Raise

Financings Feb 18, 2026 · 18:38

Liberty Defense lands Hexwave lab screening contract

Other Feb 18, 2026 · 08:00

Liberty Defense Secures Contract with Acclaimed Infectious Disease Laboratory for HEXWAVE(TM) Walkthrough Screening System

Production / Operations Feb 06, 2026 · 08:00

Liberty Defense Announces Public Filing of Registration Statement for Proposed U.S. Initial Public Offering

Financings